Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Matthew Spotniz"'
Autor:
Lana Yin Hui Lai, Daniel R. Morales, Talita Duarte-Salles, Thomas Falconer, Carlos Areia, Jitendra Jonnagaddala, Kristin Kostka, Christian G. Reich, Daniel Prieto-Alhambra, Lisa M. Schilling, Dalia Dawoud, Clair Blacketer, Marc A. Suchard, Isabelle Soerjomataram, Frank J. DeFalco, George Hripcsak, Osaid Alser, Jose D. Posada, Fredrik Nyberg, Laura Hester, William Carter, Lin Zhang, Michael E. Matheny, Sergio Fernandez-Bertolin, Ying Zhang, Waheed Ul Rahman Ahmed, María Aragón, Heba Alghoul, Karthik Natarajan, Asieh Golozar, Mengchun Gong, Martina Recalde, Patrick B. Ryan, Aedín C. Culhane, Andrea Pistillo, Vignesh Subbian, Kristine E. Lynch, Thamir M. Alshammari, Albert Prats-Uribe, Yang Shen, Donna R. Rivera, Diana Puente, Anthony G. Sena, Hokyun Jeon, Karishma Shah, Elena Roel, Nigam H. Shah, Eng Hooi Tan, Paula Casajust, Scott L. DuVall, Matthew Spotniz, Anna Ostropolets, Annalisa Trama
Publikováno v:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol 30, iss 10
Cancer Epidemiol Biomarkers Prev.
Roel, E, Pistillo, A, Recalde, M, Sena, A G, Fernández-Bertolín, S, Aragón, M, Puente, D, Ahmed, W U R, Alghoul, H, Alser, O, Alshammari, T M, Areia, C, Blacketer, C, Carter, W, Casajust, P, Culhane, A C, Dawoud, D, DeFalco, F, DuVall, S L, Falconer, T, Golozar, A, Gong, M, Hester, L, Hripcsak, G, Tan, E H, Jeon, H, Jonnagaddala, J, Lai, L Y H, Lynch, K E, Matheny, M E, Morales, D R, Natarajan, K, Nyberg, F, Ostropolets, A, Posada, J D, Prats-Uribe, A, Reich, C G, Rivera, D R, Schilling, L M, Soerjomataram, I, Shah, K, Shah, N H, Shen, Y, Spotniz, M, Subbian, V, Suchard, M A, Trama, A, Zhang, L, Zhang, Y, Ryan, P B, Prieto-Alhambra, D, Kostka, K & Duarte-Salles, T 2021, ' Characteristics and outcomes of over 300,000 patients with COVID-19 and history of cancer in the United States and Spain ', Cancer Epidemiology Biomarkers and Prevention, vol. 30, no. 10, pp. 1884-1894 . https://doi.org/10.1158/1055-9965.EPI-21-0266
Cancer Epidemiology Biomarkers and Prevention, 30(10), 1884-1894. American Association for Cancer Research Inc.
Cancer Epidemiol Biomarkers Prev.
Roel, E, Pistillo, A, Recalde, M, Sena, A G, Fernández-Bertolín, S, Aragón, M, Puente, D, Ahmed, W U R, Alghoul, H, Alser, O, Alshammari, T M, Areia, C, Blacketer, C, Carter, W, Casajust, P, Culhane, A C, Dawoud, D, DeFalco, F, DuVall, S L, Falconer, T, Golozar, A, Gong, M, Hester, L, Hripcsak, G, Tan, E H, Jeon, H, Jonnagaddala, J, Lai, L Y H, Lynch, K E, Matheny, M E, Morales, D R, Natarajan, K, Nyberg, F, Ostropolets, A, Posada, J D, Prats-Uribe, A, Reich, C G, Rivera, D R, Schilling, L M, Soerjomataram, I, Shah, K, Shah, N H, Shen, Y, Spotniz, M, Subbian, V, Suchard, M A, Trama, A, Zhang, L, Zhang, Y, Ryan, P B, Prieto-Alhambra, D, Kostka, K & Duarte-Salles, T 2021, ' Characteristics and outcomes of over 300,000 patients with COVID-19 and history of cancer in the United States and Spain ', Cancer Epidemiology Biomarkers and Prevention, vol. 30, no. 10, pp. 1884-1894 . https://doi.org/10.1158/1055-9965.EPI-21-0266
Cancer Epidemiology Biomarkers and Prevention, 30(10), 1884-1894. American Association for Cancer Research Inc.
Background: We described the demographics, cancer subtypes, comorbidities, and outcomes of patients with a history of cancer and coronavirus disease 2019 (COVID-19). Second, we compared patients hospitalized with COVID-19 to patients diagnosed with C